Entera Bio
ENTX
8 hedge funds and large institutions have $7.57M invested in Entera Bio in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
277% more capital invested
Capital invested by funds: $2.01M → $7.57M (+$5.56M)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
60% more funds holding
Funds holding: 5 → 8 (+3)
1.82% less ownership
Funds ownership: 10.19% → 8.37% (-1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$115K |
| 2 |
Renaissance Technologies
New York
|
+$111K |
| 3 |
Millennium Management
New York
|
+$88.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$50.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$34K |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $6.83M | +$115K | +50,000 | +3% |
|
|
2
Renaissance Technologies
New York
| $459K | +$111K | +48,221 | +67% |
|
|
3
Millennium Management
New York
| $147K | +$88.9K | +38,611 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $84K | +$50.6K | +21,999 | New |
|
|
XT
5
XTX Topco
George Town,
Cayman Islands
| $44K | +$26.6K | +11,559 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $6K | +$2.63K | +1,144 | +243% |
|
|
CA
7
Clearstead Advisors
Cleveland,
Ohio
| $2K | +$1.15K | +500 | New |
|
|
VF
8
Virtu Financial
New York
| – | -$34K | -31,314 | Closed |
|
|
PF
9
Phoenix Financial
Givatayim,
Israel
| – | -$14K | -12,400 | Closed |
|
|
AF
10
Allworth Financial
Folsom,
California
| – | +$230 | +100 | New |
|
ENTX Hedge Fund Activity: Q1 2021 in Review
8 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2021, worth a combined $7.57M — up 277% from $2.01M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ENTX positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Knoll Capital Management, adding an estimated $115K. The largest seller was Virtu Financial, exiting entirely with an estimated $34K sold.
- 8 institutional investors held Entera Bio (ENTX) as of Q1 2021, up from 5 in Q4 2020.
- Funds reported $7.57M of Entera Bio stock for Q1 2021, up 277% quarter-over-quarter.
- 5 funds opened new Entera Bio positions in Q1 2021 and 2 closed out, a net change of +3 holders.
- The largest Entera Bio buyer in Q1 2021 was Knoll Capital Management, an estimated $115K added.
- The largest Entera Bio seller in Q1 2021 was Virtu Financial, an estimated $34K sold.
Based on aggregated 13F filings for Q1 2021.